Roseomonas mucosa-Induced Peritonitis in a Patient Undergoing Continuous Cycler Peritoneal Dialysis: Case Report and Literature Analysis

Table 2

Summary of all cases reported to have Roseomonas spp. peritonitis with outcome.

Author	Year	Patient age/gender	Study country	Roseomonas species	Dialysis modality	Dialysis culture	Treatment received	Outcome	Modality changed
Sandoe et al. [3]	1997	62/F	UK	R. gilardii	CAPD	Positive	IP vancomycin and then IP netilmicin	Resolved	No
Bibashi et al. [4]	2000	65/F	Greece	R. fauriae	CAPD	Positive	IP vancomycin plus IP netilmicin and then ciprofloxacin	Resolved	No
Tsai et al. [5]	2012	48/M	Taiwan		CCPD	Positive	IP ceftazidime plus IP cefazolin and then PO ciprofloxacin	Resolved	No
Boyd et al. [6]	2012	19/M	USA	R. mucosa	CCPD	Positive	IP ceftazidime and then IP ciprofloxacin	Resolved	No
Matsukuma et al. [7]	2014	61/M	Japan	R. mucosa	CAPD	Positive	IP ceftazidime and then IP ciprofloxacin	Resolved	Yes, to HD
Malini et al. [8]	2016	61	Malaysia	R. gilardii	CAPD	Positive	IP ceftazidime plus IP cloxacillin and then IP meropenem	Resolved	Yes, to HD
Burstahler et al. [9]	2021	73/M	Russia	R. gilardii	CCPD	Positive	IP ceftazidime plus IP vancomycin and then IP ciprofloxacin	Resolved	No

F, female; M, male; R, Roseomonas; UK, the United Kingdom; USA, the United States of America; IV, intravenous; IP, intraperitoneal; PO, per oral; CAPD, continuous ambulatory peritoneal dialysis; CCPD, continuous cycler peritoneal dialysis; HD, hemodialysis.